Science Explorer Back to mapMap
Discussion
Company · Lexington · United States

Cubist Pharmaceuticals (United States)

In research, Cubist Pharmaceuticals (United States) stands highest in Health Sciences (#9,683 of 16,688 worldwide), Medicine (#9,037 of 14,558 worldwide) and Life Sciences (#7,446 of 11,023 worldwide), over all time.

cubist.comROR OpenAlex
World rank, all time
#25,027
of 34,923
Rank in United States
#5,216
of 7,310
Research works
370
▲ 89% vs 2018-21
Citations
22k
58.8 per fractional work
Top-10% rate
12.2%
all institutions 10.0%
vs its own fields
1.24×
1.00× is exactly expected
Open access
37%
world 40%
International
11%
world 18%
Cubist Pharmaceuticals (United States)

What is Cubist Pharmaceuticals (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #9,683 of 16,688 19.6%164
MedicineField #9,037 of 14,558 19.6%161
Life SciencesDomain #7,446 of 11,023 17.7%139

Each strip is that field's whole ranked pool, with the notch where Cubist Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Cubist Pharmaceuticals (United States) work in?

In all years, 44% of research at Cubist Pharmaceuticals (United States) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (27%), Chemistry (8%). It does 2.4× the world's share of Life Sciences.

Health Sciences: 164 fractional works · 44.4% of its workMedicine: 161 fractional works · 43.5% of its workInfectious Diseases: 43 fractional works · 11.5% of its workPharmacology: 35 fractional works · 9.4% of its workEpidemiology: 19 fractional works · 5.1% of its workSurgery: 19 fractional works · 5.1% of its workPublic Health, Environmental and Occupational Health: 7 fractional works · 1.8% of its workOncology: 6 fractional works · 1.5% of its workPhysiology: 5 fractional works · 1.3% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 0.9% of its workCardiology and Cardiovascular Medicine: 3 fractional works · 0.7% of its workPediatrics, Perinatology and Child Health: 2 fractional works · 0.7% of its workAnesthesiology and Pain Medicine: 2 fractional works · 0.6% of its workDermatology: 2 fractional works · 0.5% of its workGastroenterology: 2 fractional works · 0.5% of its workPulmonary and Respiratory Medicine: 2 fractional works · 0.5% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 0.4% of its workPsychiatry and Mental health: 2 fractional works · 0.4% of its workOphthalmology: 2 fractional works · 0.4% of its workCritical Care and Intensive Care Medicine: 1 fractional works · 0.4% of its workNephrology: 1 fractional works · 0.3% of its workSmaller subfields together: 5 fractional works · 1.4% of its workHealth Professions: 2 fractional works · 0.5% of its workGeneral Health Professions: 1 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.2% of its workNursing: 1 fractional works · 0.2% of its workNutrition and Dietetics: 1 fractional works · 0.2% of its workVeterinary: 1 fractional works · 0.2% of its workDentistry: 0 fractional works · 0.0% of its workLife Sciences: 139 fractional works · 37.5% of its workBiochemistry, Genetics and Molecular Biology: 101 fractional works · 27.4% of its workMolecular Biology: 68 fractional works · 18.5% of its workClinical Biochemistry: 11 fractional works · 3.0% of its workMolecular Medicine: 9 fractional works · 2.5% of its workGenetics: 5 fractional works · 1.2% of its workBiotechnology: 4 fractional works · 1.1% of its workCancer Research: 2 fractional works · 0.5% of its workBiochemistry: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workNeuroscience: 16 fractional works · 4.3% of its workCellular and Molecular Neuroscience: 15 fractional works · 3.9% of its workSmaller subfields together: 1 fractional works · 0.4% of its workImmunology and Microbiology: 10 fractional works · 2.6% of its workMicrobiology: 5 fractional works · 1.3% of its workApplied Microbiology and Biotechnology: 3 fractional works · 0.8% of its workImmunology: 2 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 7 fractional works · 1.9% of its workPharmacology: 3 fractional works · 0.8% of its workToxicology: 2 fractional works · 0.5% of its workPharmaceutical Science: 2 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.0% of its workAgricultural and Biological Sciences: 5 fractional works · 1.3% of its workPlant Science: 2 fractional works · 0.6% of its workFood Science: 1 fractional works · 0.3% of its workEcology, Evolution, Behavior and Systematics: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.1% of its workPhysical Sciences: 52 fractional works · 14.1% of its workChemistry: 30 fractional works · 8.1% of its workOrganic Chemistry: 25 fractional works · 6.7% of its workSpectroscopy: 3 fractional works · 0.8% of its workInorganic Chemistry: 1 fractional works · 0.4% of its workPhysical and Theoretical Chemistry: 1 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 8 fractional works · 2.2% of its workComputational Theory and Mathematics: 5 fractional works · 1.4% of its workArtificial Intelligence: 1 fractional works · 0.4% of its workSmaller subfields together: 2 fractional works · 0.5% of its workEngineering: 7 fractional works · 1.8% of its workBiomedical Engineering: 3 fractional works · 0.7% of its workElectrical and Electronic Engineering: 2 fractional works · 0.4% of its workAerospace Engineering: 1 fractional works · 0.3% of its workSmaller subfields together: 2 fractional works · 0.5% of its workMaterials Science: 3 fractional works · 0.9% of its workMaterials Chemistry: 3 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 3 fractional works · 0.8% of its workEcology: 1 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.4% of its workMathematics: 0 fractional works · 0.1% of its workChemical Engineering: 0 fractional works · 0.1% of its workEnergy: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workSocial Sciences: 15 fractional works · 4.0% of its workSocial Sciences: 4 fractional works · 1.1% of its workSociology and Political Science: 2 fractional works · 0.5% of its workEducation: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workPsychology: 4 fractional works · 1.0% of its workClinical Psychology: 2 fractional works · 0.5% of its workSocial Psychology: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 4 fractional works · 1.0% of its workAccounting: 2 fractional works · 0.4% of its workOrganizational Behavior and Human Resource Management: 1 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.2% of its workArts and Humanities: 2 fractional works · 0.4% of its workDecision Sciences: 1 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 0.3% of its workEconomics and Econometrics: 1 fractional works · 0.3% of its workALL ITS WORKCubistPharmaceuticals…370fractional works, all years
Life Sciences37%Physical Sciences14%Health Sciences44%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 25 fields, with their numbers
    1. Medicine16143.5%
    2. Health Professions20.5%
    3. Nursing10.2%
    4. Veterinary10.2%
    5. Dentistry00.0%
    1. Biochemistry, Genetics and Molecular Biology10127.4%
    2. Neuroscience164.3%
    3. Immunology and Microbiology102.6%
    4. Pharmacology, Toxicology and Pharmaceutics71.9%
    5. Agricultural and Biological Sciences51.3%
    1. Chemistry308.1%
    2. Computer Science82.2%
    3. Engineering71.8%
    4. Materials Science30.9%
    5. Environmental Science30.8%
    6. Mathematics00.1%
    7. Chemical Engineering00.1%
    8. Energy00.1%
    9. Physics and Astronomy00.1%
    1. Social Sciences41.1%
    2. Psychology41.0%
    3. Business, Management and Accounting41.0%
    4. Arts and Humanities20.4%
    5. Decision Sciences10.3%
    6. Economics, Econometrics and Finance10.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.53× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.64× its world share, 0 worksImmunology and Micro…Computer Science: 0.77× its world share, 1 worksComputer ScienceEnergy: 2.92× its world share, 0 worksEnergyEngineering: 0.33× its world share, 0 worksEngineeringMaterials Science: 1.30× its world share, 0 worksMaterials ScienceHealth Professions: 1.99× its world share, 0 worksHealth ProfessionsMedicine: 0.72× its world share, 1 worksMedicineArts and Humanities: 2.26× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 2.86× its world share, 1 worksBusiness, Management…Decision Sciences: 3.37× its world share, 0 worksDecision SciencesPsychology: 3.18× its world share, 1 worksPsychologySocial Sciences: 1.76× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.6×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Immunology and Microbiology3.64×0 works
  2. Decision Sciences3.37×0 works
  3. Psychology3.18×1 works
  4. Energy2.92×0 works
  5. Business, Management and Accounting2.86×1 works
  6. Arts and Humanities2.26×1 works
  7. Health Professions1.99×0 works
  8. Social Sciences1.76×2 works
  9. Biochemistry, Genetics and Molecular Biology1.53×1 works
  10. Materials Science1.30×0 works
  11. Computer Science0.77×1 works
  12. Medicine0.72×1 works
  13. Engineering0.33×0 works

Who are the top researchers at Cubist Pharmaceuticals (United States)?

Ranked on the quality score, Jared A. Silverman, Roland E. Dolle and Philippe Prokocimer lead among researchers whose main affiliation is Cubist Pharmaceuticals (United States).

  1. 1 Jared A. Silverman United States · #259,556 worldwide 6.2k citations · 66 works
  2. 2 Roland E. Dolle United States · #828,142 worldwide 6.9k citations · 235 works
  3. 3 Philippe Prokocimer United States · #960,759 worldwide 3.5k citations · 91 works
  4. 4 Jan Antoinette C. Romero United States · #1,467,538 worldwide 2.3k citations · 30 works
  5. 5 Aileen Rubio United States · #1,658,190 worldwide 2k citations · 41 works
  6. 6 Edward Fang United States · #1,735,676 worldwide 1.6k citations · 35 works
  7. 7 Tongchuan Li United States · #1,855,871 worldwide 1.4k citations · 19 works
  8. 8 Lee M. Techner United States · #2,124,788 worldwide 2.1k citations · 37 works
  9. 9 Karin Worm United States · #2,572,609 worldwide 637 citations · 25 works
  10. 10 Bertrand Le Bourdonnec United States · #2,757,218 worldwide 1.6k citations · 71 works
All ranked researchers at Cubist Pharmaceuticals (United States)

What are the most cited papers from Cubist Pharmaceuticals (United States)?

The most cited paper from Cubist Pharmaceuticals (United States) is "Biofilms: the matrix revisited" (Steven S. Branda, Åshild Vik, Lisa Friedman et al., 2004), with 1,821 citations. Next come "Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus" (1,472) and "Tackling antibiotic resistance" (1,077).

Most cited papers
#PaperReleasedCitations
1 Biofilms: the matrix revisited Steven S. Branda, Åshild Vik, Lisa Friedman et al. · Trends in Microbiology Review 10 Dec 2004 1,821
2 Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus Vance G. Fowler et al. · New England Journal of Medicine Open access 16 Aug 2006 1,472
3 Tackling antibiotic resistance Karen Bush et al. · Nature Reviews Microbiology Open access 2 Nov 2011 1,077
4 The Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections Robert D. Arbeit, Dennis G. Maki, Frank Tally et al. · Clinical Infectious Diseases 2 Jun 2004 697
5 Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus Jared A. Silverman, Nancy G. Perlmutter, Howard M. Shapiro · Antimicrobial Agents and Chemotherapy Open access 23 Jul 2003 662
All 60 most cited papers, with filters and sorting

Which keywords describe research at Cubist Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Antimicrobial Resistance, Healthcare-Associated Infections, Virulence Factors, Drug Discovery, Staphylococcus aureus, Clinical Management and Genetic Analysis.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology70▲ 4.7×37 topics
  2. Antimicrobial Resistance52▲ 55×6 topics
  3. Healthcare-Associated Infections42▲ 92×5 topics
  4. Virulence Factors40▲ 58×5 topics
  5. Drug Discovery40▲ 27×8 topics
  6. Staphylococcus aureus34▲ 123×2 topics
  7. Clinical Management34▲ 45×2 topics
  8. Genetic Analysis34▲ 188×1 topic
  9. MRSA34▲ 264×1 topic
  10. Antibiotic Resistance26▲ 17×7 topics
  11. Bacteremia16▲ 59×2 topics
  12. Marine Natural Products16▲ 76×2 topics
  13. Immune Modulation16▲ 30×3 topics
  14. Secondary Metabolites15▲ 43×3 topics
  15. Pharmacology15▲ 12×10 topics
  16. Natural Products14▲ 22×4 topics
  17. Antibiotics14▲ 49×3 topics
  18. Endophytic Fungi14▲ 34×2 topics
  19. Stress14▲ 9.4×3 topics
  20. Genome Sequencing14▲ 21×1 topic
  21. Microbial Metabolites14▲ 87×1 topic
  22. Antibiotic Pharmacokinetics13▲ 80×1 topic
  23. Critically Ill Patients13▲ 80×1 topic
  24. Depression13▲ 4.7×4 topics
  25. Anxiety13▲ 9.6×4 topics
  26. Neuroprotection13▲ 9.0×4 topics
  27. Signal Transduction12▲ 13×4 topics
  28. Neuropeptides11▲ 29×2 topics
  29. Opioid11▲ 51×1 topic
  30. Receptors11▲ 51×1 topic
  31. Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry11▲ 103×1 topic
  32. Medicinal Chemistry11▲ 8.1×9 topics
  33. Microorganism Identification11▲ 103×1 topic
  34. Cell Signaling11▲ 8.8×5 topics
  35. Protein-Protein Interactions11▲ 27×2 topics
  36. Ribosome11▲ 29×1 topic
  37. Translation11▲ 14×1 topic
  38. Foldamers11▲ 36×1 topic
  39. Peptide Synthesis11▲ 36×1 topic
  40. Molecular Mechanisms10▲ 14×4 topics

Which research topics does Cubist Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Education, Healthcare and Sociology Research, Organizational Change and Leadership, Crime and Detective Fiction Studies and European and International Law Studies.

Education, Healthcare and Sociology Research: 1 fractional worksOrganizational Change and Leadership: 0 fractional worksCrime and Detective Fiction Studies: 0 fractional worksEuropean and International Law Studies: 0 fractional worksComplex Systems and Deci…0Complex Systems and Decision Making: 0 fractional worksSARS-CoV-2 detection and testing: 0 fractional worksCrime, Deviance, and Social Control: 0 fractional worksSafe Handling of Antineo…0Safe Handling of Antineoplastic Drugs: 0 fractional worksEducation, Leadership, and Health Research: 0 fractional worksMedical Device Sterilization and Disinfection: 0 fractional works
Social PsychologyOrganizational Behavior and Human Resource ManagementLiterature and Literary TheoryPolitical Science and International Relations6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Education, Healthcare and Sociology Research Social Psychology 1 works
  2. 2 Organizational Change and Leadership Organizational Behavior and Human Resource Management 0 works
  3. 3 Crime and Detective Fiction Studies Literature and Literary Theory 0 works
  4. 4 European and International Law Studies Political Science and International Relations 0 works
  5. 5 Complex Systems and Decision Making Management Science and Operations Research 0 works
  6. 6 SARS-CoV-2 detection and testing Infectious Diseases 0 works
  7. 7 Crime, Deviance, and Social Control Sociology and Political Science 0 works
  8. 8 Safe Handling of Antineoplastic Drugs Occupational Therapy 0 works
  9. 9 Education, Leadership, and Health Research Education 0 works
  10. 10 Medical Device Sterilization and Disinfection Microbiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.3%not open62.7%

World: 40% of research is openly available.

with international co-authors11.2%domestic only88.8%

World: 18% is written across borders.

How has Cubist Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 89% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cubist Pharmaceuticals (United States) as a percentage of every work published that year, 0.000015% in 2024.

still counting0.0010%0.0020%Cubist Pharmaceuticals (United States)0.000062% in 202519801990200020102020

Fractional works of Cubist Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

10%20%30%Cubist Pharmaceuticals (United States)15.8% in 2014all institutions10.0% in 20142010

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 22.7% in 2007.

Other research institutions in Lexington

All research institutions in Lexington

Share Cubist Pharmaceuticals (United States)'s ranking

Cubist Pharmaceuticals (United States) on Science Explorer

A card with Cubist Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Cubist Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.